Macro Dragon WK # 27: Noisy Week Ahead with Month/Quarter/1st Half-end plus NFP Friday! Macro Dragon WK # 27: Noisy Week Ahead with Month/Quarter/1st Half-end plus NFP Friday! Macro Dragon WK # 27: Noisy Week Ahead with Month/Quarter/1st Half-end plus NFP Friday!

Macro Dragon WK # 27: Noisy Week Ahead with Month/Quarter/1st Half-end plus NFP Friday!

Macro 2 minutes to read
Kay Van-Petersen

Global Macro Strategist

Summary:  Macro Dragon = Cross-Asset Quasi-Daily Views that could cover anything from tactical positioning, to long-term thematic investments, key events & inflection points in the markets, all with the objective of consistent wealth creation overtime.


(These are solely the views & opinions of KVP, & do not constitute any trade or investment recommendations. By the time you synthesize this, things may have changed.)

Macro Dragon WK # 27: Noisy Week Ahead with Month / Quarter / 1st Half-end plus NFP Friday!


Top of Mind…

  • TGIM & welcome to WK #27
  • We did a “Love It” piece on Brazil last wk: Macro Dragon Reflections: Brazil, Commodity Rich, +210M pop, +$1.4T GDP, Hawkish BCB, 2022 Political Elections & Consistently Punching Below its Weight. Love it!
  • Where we highlighted the vast underperformance of Brazilian equities vs. their EM counterparts, as well as the Brazilian Real – both of which seem set to be breaking out to big levels of appreciation.
  • Its going to be a Noise > Signal week on a cross-asset basis, just given the significance of potential month/quarter/1Half flows, that also ends with the US NFP number on Fri (700K e 559K p).
  • The NFP could be interesting from a variety of different factors, the risk should be to the upside & yet we still have not seen a significant beat in a while.
  • A +1M number is likely to see knee-jerk USD higher, as well as US yields, with a likely headwind for commodities & 50/50 effect on US equities.
  • An in-line number 600-800K likely will be a snoozie.
  • A big miss, is actually really probably where the real tail-risk is… as it would be that much more unexpected given that federal subsidies expired across half the states in Jun. So if we print sub 400K, we should get USD & US yields lower, CMDs higher, plus decent pop up in equities.
  • Natural interpretations here are – hastening, slowing down or no effect on Fed skew towards normalization. How we are going to get from tapering $120B a month, to zero & hiking by E-2022 is a mystery to KVP. If there were two things we learned from the GFC when it comes to monetary policy: One – there are no ‘temporary measures’ & Two – there is no increase in the CPI, there is only rampant asset class inflation.
  • So this is all a game within the Meta Game of an ever increasing MMT campaign from both the MP & FP side…
  • +15% is what everyone needs to remember. +15% is the CAGR of the G4 Central Bank balance sheet expansion since 2008. In other words, the supply of fiat from just the G4, is increasing by +15% a year – that is your hurdle to just break-even.
  • So next time you’re looking at a stock & talking valuation, or asking for funding for your start up… keep in mind that capital is the commodity. $1M in funding in 2007, is +$7M in 2021… Unicorns are not what they used to be.
  • The allocation of capital to talent & compelling unique investment opportunities is really the juice & asset.


Rest of the Week & Other Reflections

  • Econ Data: Whilst we got final PMIs across the board & even an ISM Mfg. number, its really all about the NFP data out of the US on Fri. 700K is the expectation from a previous print of 559K, so far we’ve not seen any beats that can match the -634K miss from the release in May.
  • We know that over half the states had their federal subsidies expiring over this month of Jun, with most of the other half set to expire in Sep 6. So again, far from a clear picture in regards to the jobs coming back – yet intuitively one has to think it should be chunky, rather than a linear uptrend.
  • CB: No major central bank scheduled rate decisions. Worth appreciating the step-up in hikes from Russia +50bp, Brazil +75bp, Mexico +25bp (surprise), etc. The monetary divergence theme is going to create some interesting investment pockets.     
  • Worth also noting that since the Fed pivot towards making some moves in tapering on 15 Jun, only two major EM FXs (BRL & RUB) are outperforming vs. the USD.
  • Fed speak: Quite a few Fed speakers including Barkin, Quarles, Bostic.
  • ECB|EUR: Lagarde speaking twice on Tue & Thu.
  • RBNZ|NZD: Orr set to speak on Statement of Intent on Tue. Here is the link from the last one from Jul 2020.
  • Hols: Italy out on Tue, Cad out on Thu.      
  • Dragon Interviews U-Tube Channel for easier play-ability… Check out our recent Crypto Interview with The Spartan’s Group Casper B. Johansen & yes, the increased volume for regulation coming out of the US is actually a massively positive structural aspect for the space. Translation: Regulation of Crypto = Acceptance of Crypto.

-

Start<>End = Gratitude + Integrity + Vision + Tenacity | Process > Outcome | Sizing > Position.

This is The Way

Namaste,
KVP

Quarterly Outlook 2024 Q3

Sandcastle economics

01 / 05

  • Macro: Sandcastle economics

    Invest wisely in Q3 2024: Discover SaxoStrats' insights on navigating a stable yet fragile global economy.

    Read article
  • Bonds: What to do until inflation stabilises

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain inflation and evolving monetary policies.

    Read article
  • Equities: Are we blowing bubbles again

    Explore key trends and opportunities in European equities and electrification theme as market dynamics echo 2021's rally.

    Read article
  • FX: Risk-on currencies to surge against havens

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperform in Q3 2024.

    Read article
  • Commodities: Energy and grains in focus as metals pause

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities in Q3 2024.

    Read article

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)

Saxo
40 Bank Street, 26th floor
E14 5DA
London
United Kingdom

Contact Saxo

Select region

United Kingdom
United Kingdom

Trade Responsibly
All trading carries risk. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more
Additional Key Information Documents are available in our trading platform.

Saxo is a registered Trading Name of Saxo Capital Markets UK Ltd (‘Saxo’). Saxo is authorised and regulated by the Financial Conduct Authority, Firm Reference Number 551422. Registered address: 26th Floor, 40 Bank Street, Canary Wharf, London E14 5DA. Company number 7413871. Registered in England & Wales.

This website, including the information and materials contained in it, are not directed at, or intended for distribution to or use by, any person or entity who is a citizen or resident of or located in the United States, Belgium or any other jurisdiction where such distribution, publication, availability or use would be contrary to applicable law or regulation.

It is important that you understand that with investments, your capital is at risk. Past performance is not a guide to future performance. It is your responsibility to ensure that you make an informed decision about whether or not to invest with us. If you are still unsure if investing is right for you, please seek independent advice. Saxo assumes no liability for any loss sustained from trading in accordance with a recommendation.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the U.S. and other countries. App Store is a service mark of Apple Inc. Android is a trademark of Google Inc.

©   since 1992